Linzess (linaclotide) and Movantik (naloxegol) are both medications used to treat constipation, but they work in different ways and are used for different types of constipation. Linzess (linaclotide) is a guanylate cyclase-C agonist that treats constipation related to irritable bowel syndrome (IBS-C) and chronic idiopathic constipation (CIC) in adults, as well as functional constipation in children aged 6 to 17. Movantik (naloxegol), on the other hand, is an opioid antagonist specifically used to treat constipation caused by opioid pain medications in adults. Linzess is taken as a capsule once a day on an empty stomach, while Movantik is a tablet taken once daily, also on an empty stomach. Both medications are only available as brand-name products, with no generic versions. Common side effects of Linzess include diarrhea and stomach pain, whereas Movantik can cause stomach pain, diarrhea, and nausea. Additionally, Movantik may interact with other medications and can cause opioid withdrawal symptoms, which is not a concern with Linzess.